Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JNJ-64281802 in a Dengue Human Challenge Model
NCT05048875Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Feb 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mosnodenvir in dengue fever, sponsored by National Institute of Allergy and Infectious Diseases. Started Feb 2022; status: completed.
02
Drugs
mosnodenvir
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT05048875.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05048875.